Income Statement VERU CAPI London S.E.

Stocks

VCBC

KYG9341F1081

Investment Holding Companies

End-of-day quote London S.E. 2024-02-05			5-day change	1st Jan Change
0.3500 ^GBX	-.--%		-.--%	-

05-29	WINNERS & LOSERS: CelLBxHealth jumps on AstraZeneca partnership	AN
02-27	EARNINGS AND TRADING: B&M completes Jersey switch; Vox Valor in profit	AN

4cae43f0d41e31f87251.E35ve7DZtADjFXBrFp0JL36g-8VwmdQ_7-gTFEKQSZ0.YDVYM_ez3m-geDYnIetwaQn6tYJA4JEItot4eibafet5ER0Q0uuGWdBvSA

Published financial data: VERU CAPI

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: May	2020	2021	2022	2023	2025
Revenues	-	-	13.83M	5.57M	11.1M
Total Revenues	-	-	13.83M	5.57M	11.1M
Cost of Goods Sold, Total	-	-	12.59M	4.31M	10.55M
Gross Profit	-	-	1.24M	1.27M	546K
Selling General & Admin Expenses, Total	23.74K	22.45K	1.12M	1.21M	1.33M
Depreciation & Amortization - (IS)	-	-	23.66K	17.14K	17.67K
Other Operating Expenses	105K	124K	30.62K	99.2K	38.85K
Other Operating Expenses, Total	129K	147K	1.18M	1.32M	1.39M
Operating Income	-129K	-147K	67.33K	-57.48K	-840K
Interest Expense, Total	-	-	-564K	-528K	-687K
Interest And Investment Income	-	-	-	92.62K	74.96K
Net Interest Expenses	-	-	-564K	-435K	-612K
Other Non Operating Income (Expenses)	-	-	24.31K	-47.3K	181K
EBT, Excl. Unusual Items	-129K	-147K	-472K	-540K	-1.27M
Other Unusual Items	-	-	-2.72M	-29.54K	-
EBT, Incl. Unusual Items	-129K	-147K	-3.2M	-570K	-1.27M
Income Tax Expense	-	-	-49.82K	-382K	-56.19K
Earnings From Continuing Operations	-129K	-147K	-3.15M	-187K	-1.21M
Net Income to Company	-129K	-147K	-3.15M	-187K	-1.21M
Net Income - (IS)	-129K	-147K	-3.15M	-187K	-1.21M
Net Income to Common Incl Extra Items	-129K	-147K	-3.15M	-187K	-1.21M
Net Income to Common Excl. Extra Items	-129K	-147K	-3.15M	-187K	-1.21M
Per Share Items
Net EPS - Basic	-0	-0	-0	-0	-0
Basic EPS - Continuing Operations	-0	-0	-0	-0	-0
Basic Weighted Average Shares Outstanding	120M	132M	2.2B	2.37B	2.38B
Net EPS - Diluted	-0	-0	-0	-0	-0
Diluted EPS - Continuing Operations	-0	-0	-0	-0	-0
Diluted Weighted Average Shares Outstanding	120M	132M	2.2B	2.37B	2.38B
Normalized Basic EPS	-0	-0	-0	-0	-0
Normalized Diluted EPS	-0	-0	-0	-0	-0
Supplemental Items
EBITDA	-	-	91K	-40.34K	-826K
EBITA	-129K	-147K	81.5K	-42.08K	-824K
EBIT	-129K	-147K	67.33K	-57.48K	-840K
Total Revenues (As Reported)	-	-	13.83M	5.57M	11.1M
Effective Tax Rate - (Ratio)	-	-	1.56	67.09	4.42
Current Domestic Taxes	-	-	-12.58K	-	-
Current Foreign Taxes	-	-	28.08K	239	-12.75K
Total Current Taxes	-	-	15.49K	239	-12.75K
Deferred Domestic Taxes	-	-	-33.52K	-245K	61.75K
Deferred Foreign Taxes	-	-	-31.79K	-138K	-105K
Total Deferred Taxes	-	-	-65.31K	-382K	-43.44K
Normalized Net Income	-80.52K	-91.58K	-295K	-338K	-794K
Interest on Long-Term Debt	-	-	490K	528K	973K
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	19.85K	-28.67K
Selling and Marketing Expenses	-	-	-	19.85K	-20.24K
General and Administrative Expenses	15K	14K	1.12M	1.19M	1.35M
Net Rental Expense, Total	8.74K	8.45K	-	-	-

Fiscal Period: May	2020	2021	2022	2023	2025
Assets
Cash And Equivalents	191K	311K	912K	144K	53.24K
Total Cash And Short Term Investments	191K	311K	912K	144K	53.24K
Accounts Receivable, Total	-	-	2.92M	1.13M	1.86M
Other Receivables	-	50	3.52K	-	-
Total Receivables	-	50	2.92M	1.13M	1.86M
Prepaid Expenses	11.32K	5.34K	12.45K	170K	140K
Total Current Assets	203K	316K	3.85M	1.44M	2.05M
Gross Property Plant And Equipment	-	-	80.84K	85.05K	3.77K
Accumulated Depreciation	-	-	-11.3K	-34.04K	-3.77K
Net Property Plant And Equipment	-	-	69.55K	51.02K	0
Long-term Investments	-	-	10.16M	10.64M	12.44M
Other Intangibles, Total	-	-	7.04K	9.11K	3.02K
Deferred Tax Assets Long-Term	-	-	58.16K	448K	522K
Total Assets	203K	316K	14.14M	12.59M	15.01M
Liabilities
Accounts Payable, Total	-	-	2.89M	612K	2.28M
Accrued Expenses, Total	-	14.2K	42.3K	20.45K	163K
Short-term Borrowings	-	-	81.61K	94.95K	30.64K
Current Portion of Leases	-	-	17.38K	21.01K	-
Current Income Taxes Payable	-	-	17.82K	18.06K	-
Other Current Liabilities	65.95K	72.01K	158K	173K	136K
Total Current Liabilities	65.95K	86.21K	3.21M	939K	2.61M
Long-Term Debt	-	-	2.06M	2.57M	3.22M
Long-Term Leases	-	-	53.72K	32.62K	-
Total Liabilities	65.95K	86.21K	5.32M	3.54M	5.83M
Common Stock, Total	1.2M	1.44M	194K	194K	196K
Additional Paid In Capital	-	-	13.66M	13.42M	13.15M
Retained Earnings	-1.06M	-1.21M	-6.94M	-7.13M	-8.85M
Comprehensive Income and Other	-	-	1.91M	2.56M	4.69M
Total Common Equity	137K	230K	8.82M	9.05M	9.18M
Total Equity	137K	230K	8.82M	9.05M	9.18M
Total Liabilities And Equity	203K	316K	14.14M	12.59M	15.01M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	120M	144M	2.37B	2.37B	2.39B
ECS Total Common Shares Outstanding	120M	144M	-	2.37B	2.39B
Book Value / Share	0	0	0	0	0
Tangible Book Value	137K	230K	8.81M	9.04M	9.18M
Tangible Book Value Per Share	0	0	0	0	0
Total Debt	0	0	2.21M	2.72M	3.25M
Net Debt	-191K	-311K	1.3M	2.57M	3.19M
Debt Equivalent Oper. Leases	69.94K	67.62K	-	-	-
Account Code - Inventory Valuation	3	3	-	6	6
Machinery, Total	-	-	3.39K	3.57K	3.77K
Full Time Employees	-	-	-	5	3
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	6.7K	-	-

Fiscal Period: May	2020	2021	2022	2023	2025
Net Income	-129K	-147K	-3.15M	-187K	-1.21M
Depreciation & Amortization - CF	-	-	47.79K	21.65K	4.92K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	14.17K	15.4K	16.41K
Depreciation & Amortization, Total	-	-	61.95K	37.05K	21.32K
Other Operating Activities, Total	-	-	1.74K	-258K	704K
Change In Accounts Receivable	-15	5.94K	-1.19M	1.63M	-493K
Change In Inventories	-	-	33	-	-
Change In Accounts Payable	-1.09K	42.18K	940K	-2.29M	1.18M
Change in Other Net Operating Assets	-	-21.92K	3.28M	8.01K	77.79K
Cash from Operations	-130K	-120K	-48.22K	-1.05M	271K
Capital Expenditure	-	-	-3.39K	-	-
Cash Acquisitions	-	-	-292K	-	-
Sale (Purchase) of Intangible assets	-	-	-15.28K	-17.07K	-11.94K
Cash from Investing	-	-	-310K	-17.07K	-11.94K
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	625K	495K	-
Total Debt Issued	-	-	625K	495K	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-71.1K	-20.23K	-26.67K
Total Debt Repaid	-	-	-71.1K	-20.23K	-18.82K
Issuance of Common Stock	-	240K	-	-	53.26K
Other Financing Activities, Total	25.37K	-	-5.03K	-1.88K	-507
Cash from Financing	25.37K	240K	549K	473K	33.93K
Foreign Exchange Rate Adjustments	-	-	-34.7K	-170K	-357K
Net Change in Cash	-105K	120K	156K	-768K	-64.2K
Supplemental Items
Cash Interest Paid	-	-	5.03K	1.88K	507
Levered Free Cash Flow	-56.26K	-65.38K	-171K	-995K	-
Unlevered Free Cash Flow	-56.26K	-65.38K	181K	-665K	-
Change In Net Working Capital	-24.26K	-26.2K	-95.63K	650K	-
Net Debt Issued / Repaid	-	-	554K	475K	-18.82K

Fiscal Period: May	2020	2021	2022	2023	2025
Profitability
Return on Assets	-31.51	-35.29	0.58	-0.27	-
Return on Total Capital	-40.04	-49.92	0.75	-0.32	-
Return On Equity %	-64.06	-79.87	-69.53	-2.1	-
Return on Common Equity	-64.06	-79.87	-69.53	-2.1	-
Margin Analysis
Gross Profit Margin %	-	-	9	22.71	4.92
SG&A Margin	-	-	8.12	21.65	11.99
EBITDA Margin %	-	-	0.66	-0.72	-7.45
EBITA Margin %	-	-	0.59	-0.76	-7.42
EBIT Margin %	-	-	0.49	-1.03	-7.57
Income From Continuing Operations Margin %	-	-	-22.75	-3.36	-10.95
Net Income Margin %	-	-	-22.75	-3.36	-10.95
Net Avail. For Common Margin %	-	-	-22.75	-3.36	-10.95
Normalized Net Income Margin	-	-	-2.13	-6.06	-7.16
Levered Free Cash Flow Margin	-	-	-1.24	-17.86	-
Unlevered Free Cash Flow Margin	-	-	1.31	-11.94	-
Asset Turnover
Asset Turnover	-	-	1.91	0.42	-
Fixed Assets Turnover	-	-	-	92.45	-
Receivables Turnover (Average Receivables)	-	-	-	2.76	-
Short Term Liquidity
Current Ratio	3.07	3.67	1.2	1.53	0.78
Quick Ratio	2.9	3.61	1.19	1.35	0.73
Operating Cash Flow to Current Liabilities	-1.97	-1.4	-0.02	-1.12	0.1
Days Sales Outstanding (Average Receivables)	-	-	-	132.43	-
Average Days Payable Outstanding	-	-	-	148.46	-
Long Term Solvency
Total Debt/Equity	-	-	25.04	30	35.37
Total Debt / Total Capital	-	-	20.03	23.08	26.13
LT Debt/Equity	-	-	23.92	28.72	35.04
Long-Term Debt / Total Capital	-	-	19.13	22.09	25.88
Total Liabilities / Total Assets	32.54	27.25	37.62	28.11	38.83
EBIT / Interest Expense	-	-	0.12	-0.11	-1.22
EBITDA / Interest Expense	-	-	0.23	-0.04	-1.19
(EBITDA - Capex) / Interest Expense	-	-	0.22	-0.04	-1.19
Total Debt / EBITDA	-	-	17.08	-132.9	-3.97
Net Debt / EBITDA	-	-	10.03	-125.84	-3.9
Total Debt / (EBITDA - Capex)	-	-	17.54	-132.9	-3.97
Net Debt / (EBITDA - Capex)	-	-	10.3	-125.84	-3.9
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-59.7	-
Gross Profit, 1 Yr. Growth %	-	-	-	1.72	-
EBITDA, 1 Yr. Growth %	-	-	-	-144.33	-
EBITA, 1 Yr. Growth %	-14.23	13.73	-155.62	-151.63	-
EBIT, 1 Yr. Growth %	-14.23	13.73	-145.96	-185.37	-
Earnings From Cont. Operations, 1 Yr. Growth %	-14.23	13.73	2.05K	-94.04	-
Net Income, 1 Yr. Growth %	-14.23	13.73	2.05K	-94.04	-
Normalized Net Income, 1 Yr. Growth %	-14.23	13.73	222.1	14.43	-
Diluted EPS Before Extra, 1 Yr. Growth %	-14.23	3.26	29.24	-94.48	-
Accounts Receivable, 1 Yr. Growth %	-	-	-	-61.39	-
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-26.65	-
Total Assets, 1 Yr. Growth %	-34.3	56.13	4.37K	-10.94	-
Tangible Book Value, 1 Yr. Growth %	-48.52	68.38	3.73K	2.62	-
Common Equity, 1 Yr. Growth %	-48.52	68.38	3.73K	2.64	-
Cash From Operations, 1 Yr. Growth %	-16.37	15.06	-59.92	2.09K	-
Levered Free Cash Flow, 1 Yr. Growth %	-43.91	16.21	161.93	481.29	-
Unlevered Free Cash Flow, 1 Yr. Growth %	-43.91	16.21	-376.86	-467.67	-
Compound Annual Growth Rate Over Two Years
EBITA, 2 Yr. CAGR %	-12.13	-1.23	-20.46	-46.41	-
EBIT, 2 Yr. CAGR %	-12.13	-1.23	-27.7	-37.36	-
Earnings From Cont. Operations, 2 Yr. CAGR %	-12.13	-1.23	394.15	13.11	-
Net Income, 2 Yr. CAGR %	-12.13	-1.23	394.15	13.11	-
Normalized Net Income, 2 Yr. CAGR %	-12.13	-1.23	91.4	91.98	-
Diluted EPS Before Extra, 2 Yr. CAGR %	-13.71	-5.89	15.52	-73.3	-
Total Assets, 2 Yr. CAGR %	-36.06	1.28	735.22	530.82	-
Tangible Book Value, 2 Yr. CAGR %	-42.66	-6.89	702.84	526.76	-
Common Equity, 2 Yr. CAGR %	-42.66	-6.89	703.16	527.07	-
Cash From Operations, 2 Yr. CAGR %	-7.69	-12	-32.09	195.92	-
Levered Free Cash Flow, 2 Yr. CAGR %	-20.9	-19.27	74.46	290.2	-
Unlevered Free Cash Flow, 2 Yr. CAGR %	-20.9	-19.27	79.37	219.05	-
Compound Annual Growth Rate Over Three Years
EBITA, 3 Yr. CAGR %	-0.13	-4.24	-18.44	-31.13	-
EBIT, 3 Yr. CAGR %	-0.13	-4.24	-23.47	-23.59	-
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.13	-4.24	175.65	13.32	-
Net Income, 3 Yr. CAGR %	-0.13	-4.24	175.65	13.32	-
Normalized Net Income, 3 Yr. CAGR %	-0.13	-4.24	46.47	61.24	-
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.03	-8.39	4.61	-58.09	-
Total Assets, 3 Yr. CAGR %	-22.05	-13.9	257.86	296.06	-
Tangible Book Value, 3 Yr. CAGR %	-29.04	-17.89	221.34	304.42	-
Common Equity, 3 Yr. CAGR %	-29.04	-17.89	221.43	304.56	-
Cash From Operations, 3 Yr. CAGR %	-4.25	-7.59	-32.3	115.99	-
Levered Free Cash Flow, 3 Yr. CAGR %	-17.32	-10.08	19.52	160.58	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-17.32	-10.08	21.75	127.85	-
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	44.52	-2.18	-8.82	-24.08	-
EBIT, 5 Yr. CAGR %	44.52	-2.18	-12.24	-19.2	-
Earnings From Cont. Operations, 5 Yr. CAGR %	-8.78	-7.48	89.33	2.35	-
Net Income, 5 Yr. CAGR %	-8.78	-7.48	89.33	2.35	-
Normalized Net Income, 5 Yr. CAGR %	-8.78	-7.48	29.55	26.48	-
Diluted EPS Before Extra, 5 Yr. CAGR %	-16.26	-12.5	2.06	-44.05	-
Total Assets, 5 Yr. CAGR %	-23.91	-10.76	101.29	90.97	-
Tangible Book Value, 5 Yr. CAGR %	-28.43	-14.77	87.27	85.14	-
Common Equity, 5 Yr. CAGR %	-28.43	-14.77	87.3	85.17	-
Cash From Operations, 5 Yr. CAGR %	-3.93	-10.73	-20.09	47.19	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-11.64	11.46	61.75	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-11.64	12.7	49.23	-